Janux Therapeutics (JANX) Research & Development (2020 - 2025)
Historic Research & Development for Janux Therapeutics (JANX) over the last 6 years, with Q3 2025 value amounting to $34.6 million.
- Janux Therapeutics' Research & Development rose 8603.74% to $34.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $115.2 million, marking a year-over-year increase of 9249.12%. This contributed to the annual value of $68.4 million for FY2024, which is 2451.84% up from last year.
- According to the latest figures from Q3 2025, Janux Therapeutics' Research & Development is $34.6 million, which was up 8603.74% from $34.7 million recorded in Q2 2025.
- Janux Therapeutics' Research & Development's 5-year high stood at $34.7 million during Q2 2025, with a 5-year trough of $1.9 million in Q1 2021.
- Its 5-year average for Research & Development is $15.6 million, with a median of $14.1 million in 2022.
- As far as peak fluctuations go, Janux Therapeutics' Research & Development surged by 103390.86% in 2021, and later crashed by 2068.81% in 2023.
- Quarter analysis of 5 years shows Janux Therapeutics' Research & Development stood at $11.2 million in 2021, then soared by 38.19% to $15.4 million in 2022, then dropped by 20.69% to $12.2 million in 2023, then skyrocketed by 69.97% to $20.8 million in 2024, then surged by 66.44% to $34.6 million in 2025.
- Its last three reported values are $34.6 million in Q3 2025, $34.7 million for Q2 2025, and $25.1 million during Q1 2025.